Home > Publications database > Reproductive factors do not influence survival with ovarian cancer. > print

001     178602
005     20240229143550.0
024 7 _ |a 10.1158/1055-9965.EPI-21-1091
|2 doi
024 7 _ |a pmid:35064059
|2 pmid
024 7 _ |a 1055-9965
|2 ISSN
024 7 _ |a 1538-7755
|2 ISSN
024 7 _ |a altmetric:121447406
|2 altmetric
037 _ _ |a DKFZ-2022-00151
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Phung, Minh Tung
|0 0000-0002-3573-4501
|b 0
245 _ _ |a Reproductive factors do not influence survival with ovarian cancer.
260 _ _ |a Philadelphia, Pa.
|c 2022
|b AACR
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1651150603_30566
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2022 Apr 1;31(4):909-913
520 _ _ |a Background Previous studies on the association between reproductive factors and ovarian cancer survival are equivocal, possibly due to small sample sizes. Methods Using data on 11,175 people diagnosed with primary invasive epithelial ovarian, fallopian tube, or primary peritoneal cancer (ovarian cancer) from 16 studies in the Ovarian Cancer Association Consortium (OCAC), we examined the associations between survival and age at menarche, combined oral contraceptive use, parity, breastfeeding, age at last pregnancy, and menopausal status using Cox proportional hazard models. The models were adjusted for age at diagnosis, race/ethnicity, education level, and OCAC study and stratified on stage and histotype. Results During the mean follow-up of 6.34 years (SD=4.80), 6,418 patients passed away (57.4%). There was no evidence of associations between the reproductive factors and survival among ovarian cancer patients overall or by histotype. Conclusions This study found no association between reproductive factors and survival after an ovarian cancer diagnosis. Impact Reproductive factors are well-established risk factors for ovarian cancer, but they are not associated with survival after a diagnosis of ovarian cancer.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
700 1 _ |a Alimujiang, Aliya
|b 1
700 1 _ |a Berchuck, Andrew
|b 2
700 1 _ |a Anton-Cluver, Hoda
|b 3
700 1 _ |a Schildkraut, Joellen M
|b 4
700 1 _ |a Bandera, Elisa V
|0 0000-0002-8789-2755
|b 5
700 1 _ |a Chang-Claude, Jenny
|0 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
|b 6
|u dkfz
700 1 _ |a Chase, Anne
|b 7
700 1 _ |a Doherty, Jennifer Anne
|0 0000-0002-1454-8187
|b 8
700 1 _ |a Grout, Bronwyn
|b 9
700 1 _ |a Goodman, Marc T
|b 10
700 1 _ |a Hanley, Gillian E
|b 11
700 1 _ |a Lee, Alice W
|0 0000-0001-8756-7066
|b 12
700 1 _ |a McKinnon Deurloo, Cindy
|b 13
700 1 _ |a Menon, Usha
|0 0000-0003-3708-1732
|b 14
700 1 _ |a Modugno, Francesmary
|0 0000-0003-0637-1534
|b 15
700 1 _ |a Pharoah, Paul D P
|0 0000-0001-8494-732X
|b 16
700 1 _ |a Pike, Malcolm C
|0 0000-0003-4891-1199
|b 17
700 1 _ |a Richardson, Jean
|0 0000-0002-8273-6518
|b 18
700 1 _ |a Risch, Harvey A
|b 19
700 1 _ |a Sieh, Weiva
|0 0000-0003-0085-1190
|b 20
700 1 _ |a Terry, Kathryn L
|b 21
700 1 _ |a Webb, Penelope M
|0 0000-0003-0733-5930
|b 22
700 1 _ |a Wentzensen, Nicolas
|b 23
700 1 _ |a Wu, Anna H
|b 24
700 1 _ |a Pearce, Celeste Leigh
|b 25
773 _ _ |a 10.1158/1055-9965.EPI-21-1091
|g p. cebp.1091.2021 -
|0 PERI:(DE-600)2036781-8
|n 4
|p 909-913
|t Cancer epidemiology, biomarkers & prevention
|v 31
|y 2022
|x 1055-9965
909 C O |p VDB
|o oai:inrepo02.dkfz.de:178602
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2022
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-02-02
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-10
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER EPIDEM BIOMAR : 2021
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-10
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2022-11-10
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21